<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01116505</url>
  </required_header>
  <id_info>
    <org_study_id>R07122</org_study_id>
    <nct_id>NCT01116505</nct_id>
  </id_info>
  <brief_title>Treatment of Screen-detected Celiac Disease</brief_title>
  <official_title>Treatment of Screen-detected Celiac Disease in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to evaluate the natural history of celiac disease in
      asymptomatic, screen-detected subjects having positive endomysial antibodies and the effects
      of an intervention with a gluten-free diet. The investigators hypothesize that these subjects
      may have decreased general health and benefit of the dietary treatment regardless of the
      small-bowel mucosal structure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Asymptomatic, endomysial-antibody positive adults will be randomized to either continue with
      a normal, gluten-containing diet or start an intervention with a gluten-free diet
      irrespective of the small-bowel mucosal morphology. Several celiac-disease associated
      histological, serological and clinical markers will be evaluated both at baseline and after
      one year on trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Small-bowel mucosal morphology and inflammation</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endomysial antibodies</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue transglutaminase antibodies</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibodies to deamidated gliadin</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal tissue transglutaminase-specific IgA deposits</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory parameters</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>gluten-containing diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Active comparator, gluten-free diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gluten-free diet</intervention_name>
    <description>gluten-containing cereals removed from diet</description>
    <arm_group_label>Active comparator, gluten-free diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive endomysial antibodies

          -  Adults

        Exclusion Criteria:

          -  Previous celiac disease diagnosis

          -  Significant clinical symptoms

          -  Suspicion of any serious celiac disease-associated complication

          -  Suspected or diagnosed severe illness other than celiac disease

          -  Consuming oral corticosteroids or immune suppressants

          -  Marked laboratory abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katri Kaukinen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tampere, Tampere University hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Research Centre, Tampere University Hospital and University of Tampere</name>
      <address>
        <city>Tampere</city>
        <state>Pirkanmaa</state>
        <zip>33014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2010</study_first_submitted>
  <study_first_submitted_qc>May 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2010</study_first_posted>
  <last_update_submitted>August 24, 2012</last_update_submitted>
  <last_update_submitted_qc>August 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Kalle Kurppa</investigator_full_name>
    <investigator_title>M.D, Ph.D, Pediatrician</investigator_title>
  </responsible_party>
  <keyword>Celiac disease</keyword>
  <keyword>Endomysial antibodies</keyword>
  <keyword>Gluten-free diet</keyword>
  <keyword>Screen-detected</keyword>
  <keyword>Asymptomatic</keyword>
  <keyword>Bone mineral density</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

